Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002847.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 10.55 1.05 0.95
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -47.17 0.82 1.56
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 13.13 8.73 7.72
Cash 55.70 2.58 1.66
Capex -32.72 -0.56 -0.42
Free Cash Flow -28.45 0.58 0.82
Revenue 9.31 6.48 5.92
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.68 0.32 0.31
Operating Margin 11.98 0.13 0.12
ROA 35.95 0.05 0.04
ROE 28.37 0.10 0.08
ROIC 10.47 0.06 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002847.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002847.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002847.SZ is permitted for members.